A nem szteroid gyulladáscsökkentok cardiovascularis kockázata

Translated title of the contribution: Cardiovascular risk of nonsteroidal antiinflammatory drugs

Research output: Contribution to journalReview article

3 Citations (Scopus)


During the past decade, a number of original publications, reviews and metaanalyses were published on the cardiovascular safety of nonsteroidal antiinflammatory drugs (NSAIDs). As this group of medicines is among the most frequently used ones and many preparations are available over the counter, it seems to be prudent to summarise the most important results on the safety of these drugs, and underline their potentially harmful cardiovascular side effects. Nevertheless, it can also be emphasized that there are substantial differences between different compounds, and the cardiovascular risk does not depend on the ratio of COX-1/COX-2 selectivity. Cardiovascular risk can be increased by all NSAIDs with the possible exception of naproxen.

Original languageHungarian
Pages (from-to)249-255
Number of pages7
JournalLege Artis Medicinae
Issue number4
Publication statusPublished - Apr 1 2011


ASJC Scopus subject areas

  • Medicine(all)

Cite this